Tang Capital Management as of Sept. 30, 2013
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 16 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pdl Biopharma Inc cnv | 18.6 | $38M | 26M | 1.45 | |
| OPK CB 3 01FEB2033 144A BOND 01feb2033 | 15.3 | $31M | 25M | 1.24 | |
| Salix Pharmaceuticals | 9.9 | $20M | 300k | 66.88 | |
| Mirati Therapeutics | 8.8 | $18M | 1.2M | 15.15 | |
| Mannkind Corp note 3.750%12/1 | 8.5 | $17M | 17M | 1.00 | |
| Dendreon Corp note | 8.0 | $16M | 27M | 0.61 | |
| Intermune Inc note 2.500% 9/1 | 7.6 | $15M | 17M | 0.90 | |
| BioMarin Pharmaceutical (BMRN) | 6.5 | $13M | 182k | 72.17 | |
| OncoGenex Pharmaceuticals | 4.3 | $8.6M | 933k | 9.27 | |
| Savient Pharmaceuticals note | 3.6 | $7.3M | 31M | 0.24 | |
| DepoMed | 3.1 | $6.2M | 836k | 7.47 | |
| Endocyte | 3.1 | $6.2M | 466k | 13.33 | |
| Amarin Corporation Plc note 3.500% 1/1 | 1.4 | $2.8M | 2.5M | 1.10 | |
| Sophiris Bio | 1.2 | $2.3M | 500k | 4.68 | |
| Dendreon Corporation | 0.1 | $233k | 80k | 2.93 | |
| Ambit Bioscience | 0.0 | $0 | 46.00 | 0.00 |
